In 5 June press release RFG stated that the company expected a NPAT for the financial year ended 30 June 2018 of approximately $34.7 million.
Summary of cash from operating activities ($thousands) as published:
1st half 2017 - $32,568
financial year 2017 - $63,795
1st half 2018 - $3,400
The NPAT and published accounts are accounting constructs. A key consideration of how a company is performing is its cash generated from operating activities.
RFG's decline in operating performance is stunning.
One can only guess at the 2nd half's performance.
The company is under restrictive banking conditions and it is likely that it would not find another (reasonable) debt provider(s).
The company will need significant amounts of capital to among other things, upgrade or replace plant and equipment, meet its (so far undisclosed) lease obligations (of franchisees), and so on.
Additionally, if it were to sell/dispose of any of its assets the banks have a 60% clawback requirement in place.
The potential outcomes are to sell some assets (generating little meaningful funds as any purchaser will know it is a distressed sale) and/or have a significant capital raising (but at what price would funds be provided?).
Realistically, the decline in cash flow from operations has and will continue to have adverse effects on the company and its ability to implement its strategies.
- Forums
- ASX - By Stock
- RFG
- NPAT? Its cash flow that matters
NPAT? Its cash flow that matters
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RFG (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.5¢ |
Change
0.004(5.63%) |
Mkt cap ! $186.9M |
Open | High | Low | Value | Volume |
6.8¢ | 7.6¢ | 6.8¢ | $647.9K | 8.894M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 309945 | 7.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.5¢ | 116290 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 309945 | 0.074 |
1 | 27233 | 0.073 |
2 | 147000 | 0.072 |
1 | 50000 | 0.071 |
3 | 1050000 | 0.070 |
Price($) | Vol. | No. |
---|---|---|
0.075 | 116290 | 1 |
0.076 | 245385 | 3 |
0.077 | 324761 | 10 |
0.078 | 313076 | 4 |
0.079 | 1007765 | 7 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
RFG (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online